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Myocardial infarctionNicotinamide adenine dinucleotide 3-phosphate (NADPH) oxidase activity and endoplasmic reticulum (ER) stress
are increased after myocardial infarction (MI). In this study, we proposed to test whether activation of the
NADPH oxidase in the remote non-infarcted myocardiummediates ER stress and left ventricular (LV) remodel-
ing after MI. Rabbits withMI or sham operation were randomly assigned to orally receive an NADPH oxidase in-
hibitor apocynin or placebo for 30 days. The agents were administered beginning at 1 week after surgery. MI
rabbits exhibited decreases in LV fractional shortening, LV ejection fraction and theﬁrst derivative of the LVpres-
sure rise, which were abolished by apocynin treatment. NADPH oxidase Nox2 protein and mRNA expressions
were increased in the remote non-infarcted myocardium after MI. Immunolabeling further revealed that Nox2
was increased in cardiac myocytes in the remote myocardium. The apocynin treatment prevented increases in
the Nox2 expression, NADPH oxidase activity, oxidative stress, myocyte apoptosis and GRP78, CHOP and cleaved
caspase 12 protein expression in the remote myocardium. The apocynin treatment also attenuated increases in
myocyte diameter and cardiac ﬁbrosis. In cultured H9C2 cardiomyocytes exposed to angiotensin II, an important
stimulus for post-MI remodeling, Nox2 knockdown with siRNA signiﬁcantly inhibited angiotensin II-induced
NADPH oxidase activation, reactive oxygen species and GRP78 and CHOP protein expression. We conclude that
NADPH oxidase inhibition attenuates increased ER stress in the remote non-infarcted myocardium and LV remod-
eling late after MI in rabbits. These ﬁndings suggest that the activation of NADPH oxidase in the remote non-
infarctedmyocardiummediates increased ER stress, contributing tomyocyte apoptosis and LV remodeling afterMI.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Increased reactive oxygen species (ROS) contribute to left ventricu-
lar (LV) remodeling and dysfunction in heart failure [1]. Studies have
shown that nicotinamide adenine dinucleotide 3-phosphate (reduced
form) (NADPH) oxidase is a major source of ROS production in cardio-
vascular cells [2]. The NADPH oxidase complex is composed of a
membrane-bound heterodimer consisting of a catalytic gp91phox sub-
unit (also known as Nox2) and a p22phox subunit and four cytosolic
subunits (p40phox, p47phox, p67phox, and rac1) that associate with
the heterodimer in the activated enzyme [3]. Nox2, which is a major
subunit responsible for enzyme activity, has been demonstrated tocular Medicine, The Afﬁliated
ersity, 18 Yifen Street, Taiyuanincrease in the infarct site one week after myocardial infarction (MI)
in rats [4]. Nox2 protein expression is also increased in human
cardiomyocytes in the infarcted area after acute MI [5]. Studies have
shown previously that ROS and oxidative stress are increased in the
remote non-infarcted myocardium late after MI [6,7]. Increased ROS
and oxidative stress in the non-infarcted myocardium is implicated in
LV remodeling and dysfunction after MI [6,7]. However, whether
NADPH oxidase Nox2 is present in cardiac myocytes in the remote non-
infarcted myocardium late after MI in rabbits is not clear. Accordingly,
we ﬁrst determined whether NADPH oxidase Nox2 expression was
increased in cardiac myocytes in the remote non-infarcted myocardium
late after MI in rabbits. Endoplasmic reticulum (ER) stress has been
shown to increase in myocardial ischemia and reperfusion, MI and heart
failure [8–11]. Increased ER stress is associated with myocyte apoptosis
[12–14]. NADPH oxidase activation plays a role in ER stress and myocar-
dial remodeling in diabetes in mice [15]. However, it remains unclear
whether activation of NADPH oxidase mediates increased ER stress in
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this study was to test the hypothesis that activation of NADPH oxidase
mediates increased ER stress in the remote non-infarcted myocardium
and LV remodeling late after MI.
2. Materials and methods
2.1. Animal model and experimental protocol
Healthy adult male New Zealand White rabbits (2–2.5 kg) obtained
from the Academy of Military Medical Sciences were prepared for MI
produced by coronary artery ligation as described before [16]. The
animals were anesthetized by intravenous injection of pentobarbital
sodium (30 mg/kg) and artiﬁcially ventilated with a respirator
(HX-300, Taimeng Technology Co., Ltd., Chengdu, China). The heart
was exposed through a left thoracotomy. The left anterior descending
coronary artery was ligated with a 5–0 silk suture at 2–3 mm away
from the left atrial appendage. AcuteMIwas conﬁrmedwith ST segment
changes on electrocardiograms. Sham-operated animals underwent the
same surgery without coronary artery ligation. Animals with MI or
sham operation were assigned to orally receive apocynin (Calbiochem,
EMDMillipore, USA) (15mg per day) or placebo for 30 days. The agents
were administered beginning at 1 week after surgery. Animals were
closely monitored after surgery for the development of ascites, respira-
tory distress, or anorexia, and treated accordingly. The study was
approved by the Shanxi Medical University Committee on Animal
Resources and conformed to “the guiding principles in the Care and
Use of Animals” of the American Physiological Society and the Guide
for the Care and Use of Laboratory Animals as outlined by the National
Research Council.
2.2. H9C2 cardiomyocyte culture and treatment
The H9C2 cardiomyocytes were cultured in 75 cm2 ﬂask in
Dulbecco's modiﬁed Earle's medium (DMEM) (Gibco, Life Technologies,
USA) containing 4.5 g/L D-glucose, 3.7 g/L sodium bicarbonate and
110 mg/L sodium pyruvate, supplemented with 10% fetal bovine
serum (Australia) and penicillin (100 units/mL) and streptomycin
(100 μg/mL) in a humidiﬁed incubator with 95% air and 5% CO2 at
37 °C. The culture medium was changed every two or three days.
After 4 to 5 days, cells were passaged at a 1:5 ratio and seeded at the
density of 0.15 × 106 cells per 35-mm well of six-well plates,
3 × 104 cells per 20-mm well of 24-well plates or 0.64 × 104 cells per
6.4-mm well of 96-well plates. These cells were cultured for 4 days
and then performed treatments. H9C2 cells were transfected with
Nox2 siRNA (Santa Cruz Biotechnology, Santa Cruz, CA) or a scrambled
siRNA as a control using the siRNA transfection reagent system (Santa
Cruz Biotechnology) according to the manufacturer's protocol and
then incubated with angiotensin II (100 nmol/L) (Sigma-Aldrich, St.
Louis, MO) or phosphate-buffered saline containing 0.1% bovine
serum albumin for 24 h. The use of this dose was based on our pilot
studies and previous reports [17,18].
2.3. Echocardiographic and hemodynamic measurements
Two-dimensional and M-mode echocardiograms were performed
before surgery and 37 days after surgery to assess LV dimension and
function using a UCG machine (AE33, Philips) equipped with a
3–7 MHz transducer (S5-1, Philips). Maximal LV end-diastolic dimen-
sion (EDD) and end-systolic dimension (ESD) were used to calculate
LV fractional shortening (FS) by the following equation: FS =
[(EDD− ESD) × 100] / EDD. The echocardiographic data were analyzed
in a blinded manner.
For the terminal hemodynamic studies, animals were anesthetized
with intravenous pentobarbital sodium (30mg/kg). A 20-gauge catheter
ﬁlled with saline with 5 IU/mL heparin was introduced into the leftcarotid artery and connected to a pressure transducer (BL420F-PowerLab,
Taimeng Technology Co., Ltd., Chengdu, China) for measuring aortic
pressure. Another saline-ﬁlled catheter was placed into the left ventricle
via the right carotid artery for measuring the LV pressure and the ﬁrst
derivative of the LV pressure rise (dP/dt) using an electronic
differentiator. Electrocardiograms, aortic pressure, and the LV dP/dt
were recorded on a multiple-channel physiological recorder
(BL420F-PowerLab). Resting hemodynamic measurements were
obtained in triplicate over a 20-min steady-state period at least a
half hour after the catheterization. The averages of triplicates were
used for statistical analysis. The hemodynamic data were analyzed
in a blinded manner.
After hemodynamic measurements, the animals were then
sacriﬁced and the heart was removed, weighed, and rinsed in ice-cold
oxygenated normal saline. The remote non-infarcted myocardium, at
least 2 mm away from the margin of the infarct [19], was removed
and either used immediately or stored in liquid nitrogen for studies.
2.4. Myocardial infarct size
LV tissue sliceswere stained at 37 °C for 30minwith 1% triphenyltet-
razolium chloride, which stains only the viablemyocardium. Infarct size
was determined planimetrically as the percentage of unstained left
ventricle in the section as described previously [20]. For the hearts
used for biochemical assays, infarct size was estimated from the ratio
of the infarct to the whole LVweights. The animals with 28–35% infarct
sizes were used in the study.
2.5. NADPH oxidase activity
The NADPH oxidase activity was evaluated by NADPH-dependent
superoxide production examined using SOD-inhibitable cytochrome c
reduction [21]. Total protein from myocardial tissue (ﬁnal concentra-
tion 1 mg/mL) was distributed in 96-well ﬂat-bottom culture plates
(ﬁnal volume 200 μL/well). Cytochrome c (500 μmol/L) and NADPH
(100 μmol/L) were added in the presence or absence of SOD
(200U/mL) and incubated at room temperature for 30min. Cytochrome
c reductionwasmeasured at 550-nmwavelength on amicroplate reader.
Superoxide production in nmol/mg protein was calculated from the
difference between absorbance with and without SOD and extinction
coefﬁcient for change of ferricytochrome c to ferrocytochrome c,
i.e., 21.0 mmol · L−1 · cm−1.
2.6. Determination of Nox2 protein and mRNA
2.6.1. Western blot for Nox2 protein
LV myocardial tissue samples taken from the remote non-infarcted
region were homogenized in a lysis buffer containing 1 M Tris–HCl
(pH 7.4), 0.25 M sucrose, 0.5 M EDTA (pH 8.0), 100 mM dithiothreitol,
100 mM phenylmethysulfoyl ﬂuoride, apotinin (2.2 mg/mL), leupeptin
(5mg/mL). The homogenate was centrifuged at 12,000 g for 30 min at
4 °C and the supernatant was collected as protein extracts. The
protein concentration was determined using the bicinchoninic acid
protein assay reagents (Pierce, Rockford, IL). Protein extracts (80 μg)
were resolved by 12% SDS-polyacrylamide gel and transferred to
polyvinylidene ﬂuoride membranes. The membranes were blocked in
5% non-fat dry milk in Tris-buffered saline containing 0.05% Tween 20
(TBST) for 1 h at room temperature. The resulting blots were incubated
overnightwith goat polyclonal anti-Nox2 IgG (Santa Cruz Biotechnology,
Santa Cruz, CA). Mouse anti-β-actin monoclonal antibody (Abcam,
Cambridge, MA) was used to conﬁrm equal loading conditions. After
the incubation of the primary antibody, blots were washed three times
with TBST for 5 min each, incubated with the secondary antibodies
donkey anti-goat IgG-HRP (1:5000 dilution) or goat anti-mouse
IgG-HRP (1:2000 dilution) for 1 h at room temperature, again followed
by three 5-min washes with TBST. The Phototope-HRP Western blot
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visualize the bands. Autoradiograms were scanned and analyzed using
the NIH Image 1.60 program. The optical density of tissue samples
was normalized to a control sample in an arbitrary densitometry unit.
2.6.2. RT-PCR for Nox2 mRNA expression
Total RNAwas isolated frommyocardial tissue using TRIzol reagents
(Invitrogen Life Technologies, Grand Island, NY). RT-PCR was used to
measure Nox2 mRNAs. The ﬁrst strand cDNA was synthesized by
reverse transcription of 1 μg of total RNA with random primers using
an enhanced avian DuraScript™ RT-PCR kit (Sigma-Aldrich). The
cDNA was ampliﬁed using JumpStart AccuTaq LA DNA polymerase per
manufacturer's instructions in a programmable thermal controller
(PTC-100, MJ Research,Watertown,MA). The number of thermal cycles
was determined in pilot studies to optimize ampliﬁcation of each cDNA
in a linear range. The PCR products were run on a 1.5% agarose gel and
visualized with ethidium bromide. The relative amount of mRNA was
measured and normalized to levels of GAPDHmRNA. For Nox2, primers
were sense 5′-GCTTGTGGCTGTGATAAGCA-3′, and antisense 5′-ACGG
CACAGCCAGTAGAAGT-3′, resulting in a 237-bp product. For GAPDH,
primers were sense 5′-AGGTCATCCACGACCACTTC-3′, and antisense
5′-GTGAGTTTCCCGTTCAGCTC-3′, resulting in a 299-bp product.
2.7. Immunoﬂuorescence for Nox2 expression
Myocardial tissue samples from the remote non-infarcted region
were ﬁxed in 10% neutral-buffered formalin, embedded with parafﬁn,
and then sectioned. The parafﬁn sections, with a thickness of 4 μm,
were deparafﬁnated and rehydrated with xylene and graded alcohol
series. The tissue sections were washed in phosphate-buffered saline
(PBS), blocked with 10% normal donkey serum, and subsequently incu-
bated with primary antibody goat anti-Nox2 IgG (Santa Cruz Biotech-
nology, Santa Cruz, CA), and then incubated with secondary antibody
donkey anti-goat IgG conjugated FITC (Santa Cruz Biotechnology). To
identify myocytes, the myocardial tissue sections were incubated by
mouse anti-myosin heavy chainmonoclonal antibody (Chemicon Inter-
national, Temecula, CA). Goat anti-mouse IgG conjugated TRITC (Sigma-
Aldrich, St. Louis, MO) was used as the secondary antibody. Finally, the
tissue sectionswere stained by propidium iodide to visualize nuclei. For
negative control, normal goat serum was used instead of primary anti-
body for Nox2. The slides were examined under an Olympus B × 40
ﬂuorescent microscopy (Olympus, Japan).
2.8. Oxidative stress
2.8.1. Myocardial glutathione measurements
Fresh LV myocardium from the remote non-infarcted region was
homogenized in 3 vol of 1% picric acid and the supernatant was collect-
ed for measuring total glutathione using a glutathione reductase-
coupled enzymatic assay on a spectrophotometer [22]. Total glutathi-
one was calculated from a standard curve of puriﬁed glutathione,
and oxidized glutathione (GSSG) was measured by masking the re-
duced glutathione (GSH) with 2-vinyl pyridine in the enzymatic
assay. The ratio of GSH/GSSG was calculated as total tissue
oxidative stress.
2.8.2. Immunohistochemistry for myocardial 8-OHdG
The parafﬁn sections from the remote non-infarcted region were
blocked with 10% horse serum in PBS, incubated with goat polyclonal
anti-8-OHdG antibody and then incubated with biotin-conjugated
anti-goat IgG (Vector Laboratory, Burlingame, CA). The sections were
incubatedwith avidin andbiotinylatedhorseradishperoxidasemacromo-
lecular complex (Vector Laboratory), and stained with 3-amino-9-
ethylcarbazole (Vector Laboratory) and hematoxylin. For negative con-
trol, the primary antibody was omitted. The samples were examined
under light microscopy.2.9. Intracellular ROS
Intracellular ROS were measured in H9C2 cells with the ﬂuorescent
probe carboxy-H2DCFDA as described previously [23]. Brieﬂy,
carboxy-H2 DCFDA (Molecular Probes, Eugene, OR, USA) was dissolved
in absolute ethanol and diluted with cell culture medium to a ﬁnal con-
centration of 5 mmol/L. The cells were incubated with 5 AM carboxy-
H2DCFDA at 37 °C for 1 h. The cells were collected from the plates
with a cell scraper. The ﬂuorescence intensity per culture plate well
was quantiﬁed using a Coulter Elite ﬂow cytometer (Coulter Electronics,
Hialeah, FL, USA) with excitation wavelength at 488 nm and emission
wavelength at 530 nm. The ﬂuorescence intensity of treated cells was
determined in comparisonwith control cells (diluent only: PBS contain-
ing 0.1% bovine serum albumin without drug treatment).
2.10. ER stress
2.10.1. Immunoblotting for ER stress
The LVmyocardial tissue sampleswere homogenized in a lysis buffer
(Cell Signaling Technology, Inc., Danvers, MA), and prepared for either a
whole tissue lysate or ER membrane fraction by centrifugation at
12,000 ×g or 100,000 ×g, respectively. The protein extracts (20–40 μg)
were resolved by 8–12% SDS-polyacrylamide gel and transferred to
polyvinylidene ﬂuoride membranes. The membranes were blocked in
5% non-fat dry milk in Tris-buffered saline containing 0.05% Tween 20
(TBST) for 1 h at room temperature. The resulting blots were incubated
overnight with mouse monoclonal anti-GRP78 antibody (BD Bioscience,
San Jose, CA), mouse monoclonal anti-CHOP/GADD153 antibody (Santa
Cruz Biotechnology, Santa Cruz, CA) or rat monoclonal anti-caspase 12
antibody (Sigma-Aldrich, St Louis, MO). Mouse anti-GAPDHmonoclonal
antibody (Abcam, Cambridge, MA) was used to conﬁrm equal loading
conditions. The immunoblotting signals were analyzed as described in
the Western blotting for Nox2 protein section.
2.10.2. Immunohistochemistry for ER stress
LV tissue sections were incubated with mouse monoclonal anti-
GRP78 antibody (BD Bioscience, San Jose, CA), mouse monoclonal
anti-CHOP/GADD153 antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) or rat monoclonal anti-caspase 12 antibody (Sigma-Al-
drich, St Louis, MO), and then incubated with biotin-conjugated
anti-mouse or anti-rat IgG (Vector Laboratory, Burlingame, CA).
The sections were incubated with avidin and biotinylated horserad-
ish peroxidase macromolecular complex (Vector Laboratory), and
stained with 3-amino-9-ethylcarbazole (Vector Laboratory) and he-
matoxylin. For negative control, the primary antibody was omitted.
The samples were examined under an Olympus IX51 light
microscope (Olympus, Japan).
2.11. Measurements of myocyte apoptosis
2.11.1. TUNEL assay
LV tissue sections were stained using the Apoptosis Detection
System (Promega, Madison, WI) per the manufacturer's instructions.
Brieﬂy, the sections were incubated with terminal deoxynucleotidyl
transferase andﬂuorescein-labeled dUTP. To identify the cardiomyocytes,
the sectionswere incubatedwithmouse anti-myosin heavy chainmono-
clonal antibody (Chemicon International, Temecula, CA). Finally, to iden-
tify all nuclei (non-apoptotic and apoptotic), sections were stained with
propidium iodide (Sigma-Aldrich, St Louis, MO). The samples were ana-
lyzed under a ﬂuorescence microscope. The number of apoptotic nuclei
was calculated per 10,000 cardiomyocytes.
2.11.2. Caspase 3 activity
Caspase 3 activity was assessed by a Caspase-3 Colorimetric Assay
Kit (R&D Systems, Minneapolis, MN, USA). The cleavage of the substrate
AB
C
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wavelength light.
2.12. Measurements of myocyte size
The LV tissue sectionswere stained with hematoxylin and eosin and
were examined under a light microscope (AX 10, Zeiss). Five random
ﬁelds from each of the four non-serial tissue sections per animal were
analyzed so that 60 myocytes per animal were measured. The myocytes
with nuclei in the middle or near the middle were selected for the analy-
sis. The quantiﬁcation of myocyte diameter was determined using NIH
ImageJ software as described previously [22].
2.13. Measurements of cardiac ﬁbrosis
The LV tissue sections were stained with Masson's trichrome kit
(Sigma) and examined under a light microscope (AX 10, Zeiss).
2.14. Statistical analysis
Results are presented as means ± SE. Student's t test for unpaired
data was used to determine the statistical signiﬁcance of differences
between the two means. Pearson product–moment correlation coefﬁ-
cient analysis was used to determine the relationship between Nox2
protein and GRP78, CHOP or cleaved caspase 12 protein. The statistical
signiﬁcance of differences among groupswas determined using analysis
of variance and the Bonferroni correction for multiple comparisons. A
difference of P b 0.05 was considered signiﬁcant.
3. Results
3.1. Mortality
A total of twenty nine rabbits underwent sham operation (n = 12)
or coronary artery ligation (n = 17). One rabbit died within 24 h after
MI. Sixteen rabbits who survived 1 week after coronary artery ligation
were randomized to receive apocynin (n = 8) or placebo (n = 8).
One rabbit died in the MI placebo group and none died in the MI
apocynin group. None of the rabbits died in the sham placebo group
(n = 6) and sham apocynin group (n = 6).
3.2. Echocardiographic and resting hemodynamic data
Table 1 summarizes the body and heart weights in the sham andMI
rabbits with placebo or apocynin treatment. There were no signiﬁcant
differences in body weight among groups. Heart weight, LV weight,
the ratio of LVweight to body weight and the ratio of total heart weight
to body weight tended to increase after MI compared with sham
operation, and the increases were attenuated by the treatment of
apocynin. Lung weight and liver weight were slightly increased after
MI compared with the sham operation, but did not reach statisticalTable 1
Body and organ weights and infarct size.
Sham placebo Sham apocynin MI placebo MI apocynin
BW, kg 2.08 ± 0.11 2.12 ± 0.14 2.13 ± 0.08 2.26 ± 0.04
HW, g 4.03 ± 0.10 4.10 ± 0.2 5.05 ± 0.54 4.54 ± 0.34
LVW, g 2.32 ± 0.12 2.38 ± 0.11 3.18 ± 0.34 2.78 ± 0.12
LVW/BW, g/kg 1.13 ± 0.12 1.11 ± 0.14 1.49 ± 0.12 1.24 ± 0.02
Total HW/BW, g/kg 1.98 ± 0.16 1.99 ± 0.12 2.36 ± 0.12 2.01 ± 0.11
Lung weight (g) 9.5 ± 0.37 9.3 ± 0.41 10.6 ± 0.8 10.1 ± 0.3
Liver weight (g) 47.4 ± 6.5 48.1 ± 6.2 57.6 ± 4.7 52.0 ± 4.3
Infarct size (%) 32.0 ± 3.1 34.2 ± 1.0
Values are means ± SEM. n = 6–8. MI, myocardial infarction;
BW, body weight; HW, heart weight; LVW, left ventricular weight.signiﬁcance. There was no statistical difference in infarct size between
the MI placebo group and MI apocynin group.
The MI rabbits exhibited decreases in LV FS, LV ejection fraction and
LV dP/dt over the 30-day period compared with the sham-operated
rabbits. The NADPH oxidase inhibitor apocynin had no effect in sham
animals, but attenuated the decreases of LV FS, LV ejection fraction
and LV dP/dt in MI animals (Fig. 1).
3.3. NADPH oxidase activity and Nox2 expression in the remote
myocardium
To determine the source of ROS in the remote non-infarctedmyocar-
dium, we measured the NADPH oxidase activity by SOD-inhibitable
cytochrome c reduction. Fig. 2A shows that the NADPH oxidase activity
was signiﬁcantly higher in the MI rabbits compared with the sham
animals and the change was prevented by the treatment of apocynin.
Nox2 is a major subunit responsible for the NADPH oxidase activity.
Western blotting revealed that Nox2 protein in the rabbit LV tissue was
detected as a band at 75 kDa. Nox2 protein was signiﬁcantly increased
in the remote non-infarcted myocardium after MI compared with the
sham operation (Fig. 2B). Similarly, Nox2 mRNA expression examined
by RT-PCR was higher in MI animals compared with the sham
(Fig. 2C). The apocynin treatment prevented the increases in Nox2
protein and mRNA expressions in the remote myocardium (Fig. 2B
and C).
To assess which cell types in the rabbit heart expressed Nox2, we
performed immunoﬂuorescent staining on the LV sections from the
sham and MI groups. Fig. 2D shows that Nox2 expression was mainlyFig. 1. Changes in left ventricular (LV) fractional shortening (FS), LV ejection fraction (EF)
and the ﬁrst derivative of LV pressure (dP/dt) rise in sham andMI rabbits with placebo or
apocynin treatment. Values are means ± SEM; n = 6–8. *P b 0.05 vs. sham placebo or




Fig. 2. Changes inNADPHoxidase activity, Nox2 expression and oxidative stress in the remote non-infarctedmyocardium inMI rabbits and left ventricularmyocardium in sham-operated
rabbits with placebo or apocynin treatment. Panel A: NADPH oxidase activity. Values are means ± SEM; n = 6–8. *P b 0.05 vs. sham placebo or sham apocynin group. #P b 0.05 vs. MI
placebo group. Panel B: NADPH oxidase Nox2 protein expression. The upper panel shows the representative Western blots of Nox2. The lower panel shows the densitometry analysis.
Values are means ± SEM; n = 6–8. *P b 0.05 vs. sham placebo or sham apocynin group. #P b 0.05 vs. MI placebo group. Panel C: NADPH oxidase Nox2 mRNA expression. The upper
panel shows the representative gel of Nox2 mRNA. The lower panel shows the densitometry analysis. Values are means ± SEM; n = 6–8. *P b 0.05 vs. sham placebo or sham apocynin
group. #P b 0.05 vs. MI placebo group. Panel D: immunoﬂuorescence for Nox2 expression. Nox2 expression is shown by green ﬂuorescence in the left panel. Cardiomyocytes identiﬁed
bymyosin heavy chain staining are shown in red in the right panel. Nuclei stained by propidium iodide are shown in yellow in the right panel. Bar= 25 μm. Panel E: reduced glutathione
to oxidized glutathione (GSH/GSSG) ratio. Values are means ± SEM, n = 6–8. *P b 0.05 vs. sham placebo or sham apocynin group. #P b 0.05 vs. MI placebo group. Panel F: the photomi-
crographs of left ventricular tissue sections showing 8-hydroxydeoxygaunosine (8-OHdG) staining. 8-OHdGpositive staining is shown in red. All nuclei stained by hematoxylin are shown
in blue. Bar = 25 μm.
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the remote non-infarcted myocardium after MI. Nox2 was also
expressed in endothelial cells, albeit at a low level (data not shown).
The apocynin treatment prevented the increase in the Nox2 expression
in cardiomyocytes in the remotemyocardium. To further conﬁrm the
Nox2 expression in the cardiomyocytes, we performed the immuno-
ﬂuorescent double staining using Nox2 and the macrophage maker
antibodies in the myocardium 3 days after MI since Nox2 has beenshown to express in macrophages [24]. We found that Nox2 was
expressed inmacrophages in the infarct and border zones (Supplementa-
ry Fig. 1). Since the macrophages are not present in the remote non-
infarctedmyocardium afterMI [25], Nox2was not detected in themacro-
phages in the remote myocardium late after MI.
P47phox translocation to themembrane is implicated in the NADPH
oxidase activation [21]. We found that 47phox in the membrane frac-
tion was increased in the remote non-infarcted myocardium after MI
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the apocynin treatment (Supplementary Fig. 2A and B). In addition,
other subunits of the NADPH oxidase such as p22phox and p67phox
did not differ statistically among groups (Supplementary Fig. 2C, D, E,
F and G).
3.4. Myocardial oxidative stress in the remote myocardium
Myocardial GSSG content was increased and the ratio of GSH/GSSG
was decreased in the remote non-infarcted myocardium after MI com-
pared with the sham operation, indicating that cardiac oxidative stress
was increased in MI animals (Fig. 2E). To further conﬁrm the increased
myocardial oxidative stress after MI, we detectedmyocardial 8-OHdG, a
sensitive and speciﬁc marker of DNA damage induced by oxidative
stress, using immunohistochemical staining. Fig. 2F shows that the
staining intensities of 8-OHdG were stronger in the cardiomyocytes in
the remote non-infarcted myocardium compared with the sham-
operated animals. As for the intracellular localization, positive 8-OHdG
stains in theMI rabbits weremainly in the cytosol and to a lesser extent
in the nuclei of the cardiomyocyte in the remote non-infarctedmyocar-
dium. The apocynin treatment prevented the increase in oxidative
stress in the remote myocardium (Fig. 2 E and F).
3.5. NADPH oxidase inhibition attenuates increased ER stress in the remote
myocardium
Nox2, GRP78, CHOP and cleaved caspase 12 proteinswere increased
in the remote non-infarctedmyocardium of theMI rabbits (1.62± 0.45,
1.38 ± 0.16, 1.90 ± 0.17, 1.33 ± 0.16, arbitrary units, respectively,
P b 0.005) compared with the sham animals (1.04 ± 0.01, 1.01 ±
0.01, 1.04 ± 0.01, 1.02 ± 0.01, respectively). There was a positive
correlation between Nox2 and GRP78 (r2 = 0.58, P b 0.001), CHOP
(r2 = 0.84, P b 0.001) and cleaved caspase 12 (r2 = 0.57, P b 0.001).
To further determine the relationship between the NADPH oxidase
activity and ER stress, we administered the NADPH oxidase inhibitor
apocynin to rabbits for 30 days at one week after surgery. Fig. 3(A–G)
shows that the apocynin treatment had no effect in the sham-A
C
Fig. 3. Changes in GRP78, CHOP and cleaved caspase 12 proteins in sham and MI rabbits with p
cleaved caspase 12, respectively. Equal loading of proteins is illustrated by GAPDH bands. Pane
*P b 0.02 vs. sham placebo or sham apocynin group; #P b 0.05 vs. MI placebo group.operated animals, but signiﬁcantly attenuated the increases in GRP78,
CHOP and cleaved caspase 12 protein expressions in the remote non-
infarcted myocardium. Immunohistochemical staining also revealed
that the expressions of GRP78, CHOP and cleaved caspase 12 were
increased in the remote non-infarcted myocardium and the increase
was attenuated by the treatment of apocynin (Fig. 4). In addition, the
expression of cleaved ATF-6β proteinwas increased in the remotemyo-
cardium and the increase was attenuated by the treatment of apocynin
(Supplementary Fig. 3A and B). PERK and IRE1α protein expressions
had no change in all experimental groups (Supplementary Fig. 3C, D,
E, F and G and Fig. 4).
3.6. NADPH oxidase inhibition attenuates myocyte apoptosis in the remote
myocardium
Fig. 5 shows that the caspase 3 activity and the number of TUNEL
positive nuclei were signiﬁcantly increased in the remote non-
infarcted myocardium of the MI rabbits compared with the sham opera-
tion and the increases were attenuated by the treatment of apocynin.
3.7. NADPHoxidase inhibition attenuatesmyocyte hypertrophy and cardiac
ﬁbrosis
Fig. 6 shows that the myocyte diameter measured histologically
increased in the remote non-infarcted myocardium of the MI rabbits
compared with the sham operation, and the increase was attenuated
by the treatment of apocynin. Fig. 7 shows that myocardial ﬁbrosis
assessed by Masson trichrome staining was increased in the remote
myocardium of theMI rabbits, and the increase was prevented by treat-
ment with apocynin.
3.8. NADPH oxidase inhibition attenuates angiotensin II-induced ROS and
ER stress in the H9C2 cardiomyocytes
To determine the direct role of NADPH oxidase activation in the ER
stress, we transfected with Nox2 siRNA in the H9C2 cardiomyocytes
and then exposed the cells to angiotensin II, which is implicated inB
D
lacebo or apocynin treatment. Panel A: representative Western blots of GRP78, CHOP and
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Fig. 4. Immunohistochemistry for GRP78, CHOP and cleaved caspase 12 protein expression in sham andMI rabbits with placebo or apocynin treatment. GRP78, CHOP and cleaved caspase
12 positive staining is shown in red. All nuclei stained by hematoxylin are shown in blue. Bar = 50 μm. The graphs show the relative expression of myocardial GRP78, CHOP and cleaved
caspase 12 in the four groups. Values are means ± SEM. n = 6–8. *P b 0.02 vs. sham placebo or sham apocynin group; #P b 0.05 vs. MI placebo group.
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shows that knockdown of Nox2 signiﬁcantly attenuated increased
NADPH oxidase activity, ROS and GRP78 and CHOP protein expressions
in the H9C2 cardiomyocytes after exposure to angiotensin II.
4. Discussion
Our study demonstrates that (1) NADPH oxidase Nox2 expression
was increased in the cardiomyocytes in the remote non-infarcted myo-
cardium late after MI in rabbits, (2) activation of NADPH oxidase in the
remote myocardium coincided with increases in GRP78, CHOP and
cleaved caspase 12 protein expressions, (3) NADPH oxidase inhibition
attenuates increased ER stress and myocyte apoptosis, and (4) NADPH
oxidase inhibition attenuatesmyocyte hypertrophy, myocardial ﬁbrosis
and LV remodeling. The ﬁndings suggest that the activation of the
NADPH oxidase in the remote non-infarcted myocardium mediates
increased ER stress, contributing tomyocyte apoptosis and LV remodel-
ing after MI.4.1. ROS and oxidative stress in the remote non-infarcted myocardium
Studies have shown that ROS and oxidative stress are increased in
the infarcted myocardium early after MI [4,26,27]. Our present
results have demonstrated that oxidative stress assessed by
8-hydroxydeoxygaunosine and GSH/GSSG is increased in the remote
non-infarcted myocardium 37 days after MI produced by the ligation
of the left anterior descending coronary artery in rabbits. These ﬁndings
are consistent with other reports showing that ROS and oxidative stress
are increased in the remote non-infarcted region in the chronic phase
after MI [28–30]. Oxidative stress assessed by malondialdehyde is
increased in the remote non-infarcted myocardium 7 weeks after
MI in rats [19]. Hydroxyl radical and malondialdehyde are increased
in the remote non-infarcted myocardium 4 weeks after MI in mice
[29,30]. Oxidative stress assessed by the ratio of GSH/GSSG and
4-hydroxynonenal is increased in the remote non-infarcted myocar-
dium 12 weeks after MI produced by the occlusion of the marginal
branch of the left circumﬂex coronary artery in rabbits [31]. These
AB
Fig. 5. Changes in caspase 3 activity and myocyte apoptosis in sham and MI rabbits with
placebo or apocynin treatment. Panel A: caspase 3 activity. Values are means ± SEM.
n = 6–8. *P b 0.05 vs. sham placebo or sham apocynin group; #P b 0.05 vs. MI placebo
group. Panel B: the number of myocyte apoptosis by TUNEL assay. Values are means ±
SEM. n=5–6. *P b 0.01 vs. shamplacebo or sham apocynin group; #P b 0.05 vs.MI placebo
group.
Sham placebo MI placebo MI apocynin
Fig. 7. Cardiac ﬁbrosis in sham and MI rabbits with placebo or apocynin treatment. The
upper panels show representative photomicrographs of LV tissue sections with Masson
trichrome staining. Myocardium stains are in red, and collagen stains are in blue. Bar =
100 μm. The lower panel shows the quantiﬁcation of cardiac ﬁbrosis measured using
NIH ImageJ. Values are means ± SEM; n = 4–6. *P b 0.05 vs. sham placebo or sham
apocynin group; #P b 0.05 vs. MI placebo group.
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non-infarcted myocardium are implicated in the progression of LV
remodeling and failure after MI.
4.2. Sources of ROS in the remote non-infarcted myocardium
The cardiomyocytes, ﬁbroblasts, endothelial cells, vascular smooth
muscle cells, and inﬁltrating inﬂammatory cells in the heart can generate
ROS. Potential sources of ROS in these cell types include themitochondrial
electron transport chain, ‘uncoupled’ nitric oxide synthases, xanthine
oxidases, cytochrome P450 and NADPH oxidases [32]. Mitochondrial
ROS are increased in the remote non-infarcted myocardium 4 weeksSham+placebo MI+placebo MI+apocynin
Fig. 6.Myocyte size in sham andMI rabbitswith placebo or apocynin treatment. The upper
panels show representative photomicrographs of LV tissue sections stained by hematoxy-
lin and eosin. Bar=25 μm. The lower panel shows the quantiﬁcation ofmyocyte diameter
measured usingNIH ImageJ. Values aremeans±SEM;n=4–6. *P b 0.05 vs. shamplacebo
or sham apocynin group; #P b 0.05 vs. MI placebo group.afterMI inmice [33]. Uncoupled endothelial nitric oxide synthase-derived
superoxide is increased in the remote myocardium after MI in rats [34].
Xanthine oxidase-generated superoxide is increased in the remote non-
infarcted myocardium 4 weeks after MI in mice and xanthine oxidase
inhibitor allopurinol reduces the increase [35]. TheNADPHoxidase inhibi-
tion attenuates oxidative stress in the remote non-infarcted myocardium
late after MI in rabbits, suggesting that NADPH oxidase generates ROS in
the remote myocardium [36,37]. Among these sources, the NADPH oxi-
dasesmay be implicated inwhich they generate ROS in a highly regulated
manner. NADPH oxidases can stimulate further ROS production from one
or more of the above enzymes [32,38]. In addition, angiotensin II or
norepinephrine, which plays an important role in post-MI myocardial
remodeling, has been shown to mediate NADPH oxidase activation in
the cardiomyocytes [26]. NADPH oxidase has two membrane subunits
Nox2 and p22phox, and four cytosolic subunits p47phox, p67phox,
p40phox and Rac. Five Nox isoforms (Nox1 to 5) form the basis of distinct
NADPH oxidases. Nox2 and Nox4 are expressed in cardiovascular cells [2,
32,39]. Nox2 expression has been shown to increase in the infarct site
after acute MI in animals and patients [4,5]. Our present study has
shown that Nox2 protein and mRNA expressions were increased in the
remote non-infarcted myocardium 37 days after MI in rabbits. Immuno-
ﬂuorescence staining indicates that Nox2 is mainly expressed in the
cardiomyocytes in the remote myocardium after MI. We have further
demonstrated that NADPH oxidase activity and oxidative stress are
increased in the remote myocardium 37 days after MI. These results are
consistent with previous reports showing that Nox2 expression and oxi-
dative stress are increased in the remote myocardium 4 weeks after MI
in mice, and the increases were attenuated in Nox2 knockout mice [40].
These ﬁndings suggest that NADPH oxidase subunit Nox2 is one of
major sources of ROS in the remote non-infarcted myocardium in the
chronic phase of MI. A recent study has shown that NADPH oxidase sub-
unit Nox4 is amajor source of ROS in the failing heart andmediatesmito-
chondrial and cardiac dysfunctions during pressure overload [41].
However, a study from Shah's group has shown that Nox4 mediates
protection against chronic load-induced stress in mouse hearts [42].
Nox5 expression has also been shown to increase in the intramyocardial
blood vessels and cardiomyocytes after acute MI in humans [43]. It
remains to be elucidated whether Nox4 or Nox5 is one of the major





























































































Fig. 8. Changes inNADPHoxidase activity, intracellular reactive oxygen species andGRP78 and CHOPprotein expression inH9C2 cardiomyocytes transfectedwith Nox2 siRNA or a scram-
bled siRNA and then incubated with angiotensin II (Ang II, 100 nmol/L) or phosphate-buffered saline containing 0.1% bovine serum albumin as a control for 24 h. Panel A: NADPH oxidase
activity. Values aremeans± SEM; n= 3–4. *P b 0.05 vs. scrambled siRNA control group. #P b 0.05 vs. scrambled siRNA Ang II group. Panel B: intracellular reactive oxygen species asmea-
sured by carboxy-H2DCFDA ﬂuorescence intensity. Values are means± SEM; n= 3–4. *P b 0.05 vs. scrambled siRNA control group. #P b 0.05 vs. scrambled siRNA Ang II group. Panels C:
representativeWestern blots of GRP78 and CHOP, respectively. Equal loading of proteins is illustrated byGAPDH bands. Panels D and E: respective group densitometry analysis. Values are
means ± SEM; n = 4–5. *P b 0.05 vs. scrambled siRNA control group. #P b 0.05 vs. scrambled siRNA Ang II group.
813B. Li et al. / Biochimica et Biophysica Acta 1852 (2015) 805–8154.3. NADPH oxidase, ER stress and post-MI myocardial remodeling
A prior study has shown that ER stress is increased in the pressure
overload-induced heart failure and human heart failure, and prolonged
ER stress is associated with myocyte apoptosis. Recent studies have
shown that oxidative stress, ER stress and myocyte apoptosis are
increased in the remote non-infarcted myocardium after MI [9,14,44].
Oxidative stress mediates ER stress and apoptosis in cultured cells and
in rabbits with autoimmune myocarditis [12,45]. NADPH oxidase
activation is associated with myocyte apoptosis after MI [37,40]. Looi
et al. have shown that the NADPH oxidase subunit Nox2 deﬁciency
attenuates apoptosis, advanced cardiac remodeling and contractile
dysfunction after MI [40]. However, the study in Nox2 knockout mice
does not 1) establish which Nox2-expressing cell types are responsible
for post-MI myocardial remodeling, 2) identify which cell types of
apoptosis play a role in post-MI remodeling, and 3) investigate the
role of ER stress in myocyte apoptosis after MI [40]. In the present
study, we chose the clinically relevant intervention that NADPH oxidase
inhibitor apocynin was administered 1 week after MI to investigate the
role of NADPH oxidase activation in ER stress, myocyte apoptosis and
myocardial remodeling late after MI.We found that the NADPH oxidase
Nox2 expression, NADPH oxidase activity and oxidative stress were
increased in the remote non-infarcted myocardium 37 days post-MI.
We also found that increasedNADPHoxidaseNox2 in the cardiomyocytesin the remote non-infarcted myocardium was associated with increased
ER stress, as evidenced by the positive correlations between Nox2 and
GRP78 and CHOP protein expressions. Moreover, we found that the inhi-
bition of NADPH oxidase by apocynin attenuated GRP78 and CHOP pro-
tein expressions in the remote non-infarcted myocardium late after MI.
In addition, apocynin attenuated caspase 12 activity andmyocyte apopto-
sis after MI. These ﬁndings suggest that the increased NADPH oxidase
subunit Nox2 expression in the cardiomyocytes plays an important
role in ER stress andmyocyte apoptosis in the remote non-infarctedmyo-
cardium late after MI. We also found that knockdown of Nox2 inhibited
increased ROS and ER stress in cultured cardiomyocytes after expo-
sure to angiotensin II, an important stimulus for post-MI myocardial
remodeling, indicating the direct role of Nox2 in ER stress in the
cardiomyocytes after exposure to remodeling stimuli. Furthermore, we
found that apocynin attenuated myocyte hypertrophy and interstitial
and perivascular ﬁbrosis in the remote non-infarcted myocardium, indi-
cating that the activation of NADPH oxidase is implicated in post-MI LV
remodeling. Recent studies have shown that upregulation of Nox4 pro-
motes apoptosis in cardiac myocytes in vitro [46]. Nox4 contributes to
cardiac oxidative stress, hypertrophy and dysfunction in mice after pres-
sure overload [41,47]. Nox5expression is increased in the intramyocardial
blood vessels and cardiomyocytes after acute MI in humans [43]. How-
ever, whether Nox4 and Nox5 are associated with ER stress and myo-
cardial remodeling after MI remains to be investigated.
814 B. Li et al. / Biochimica et Biophysica Acta 1852 (2015) 805–8154.4. Implications
The activation of NADPH oxidase coincides with an elevation of ER
stress in the remote non-infarctedmyocardium late afterMI. The inhibi-
tion of NADPH oxidase attenuates ER stress and post-MI LV remodeling.
This is the ﬁrst study to demonstrate the relationship between NADPH
oxidase and ER stress late after MI, suggesting that the NADPH oxidase
activation in the remote non-infarcted myocardium induces ER stress,
leading to myocyte apoptosis and myocardial remodeling and dysfunc-
tion late after MI. NADPH oxidase and ER stress could be therapeutic
targets for heart failure after MI.
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